Lu AF95245
Alternative Names: Lu-AF95245Latest Information Update: 28 Jan 2023
At a glance
- Originator Lundbeck A/S
- Class Neuropsychotherapeutics; Small molecules
- Mechanism of Action Potassium channel agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Mental disorders
Most Recent Events
- 28 Jan 2023 No recent reports of development identified for phase-I development in Mental-disorders(In volunteers) in Netherlands (PO, Liquid)
- 10 Dec 2019 Phase-I clinical trials in Mental disorders (In volunteers) in Netherlands (PO) (NCT04199585)